ArticleCureus2025
The Great Pretender: Xanthogranulomatous Prostatitis Mimicking Prostate Cancer.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xanthogranulomatous prostatitis (XGP) is a rare chronic inflammatory condition of the prostate that can clinically and radiologically mimic prostate cancer (PCa). We present a case of XGP in an elderly male with markedly elevated prostate-specific antigen (PSA) levels and imaging findings suggestive of locally advanced PCa. A 66-year-old male with a two-month history of intermittent fever was incidentally found to have two vesical calculi (13 mm and 9 mm) and grade 3 prostatomegaly (57 cc) with a large median lobe. He reported no lower urinary tract symptoms (LUTS). The patient underwent elective cystolithotripsy but developed hematuria, necessitating cystoscopic fulguration of the bladder neck. Postoperatively, his serum PSA was 100 ng/mL. Multiparametric MRI (mpMRI) revealed a Prostate Imaging Reporting and Data System (PIRADS) 5 lesion in the left transition zone with extraprostatic extension (stage T3b) and a PIRADS 2 lesion in the right peripheral zone. Ga-68 positron emission tomography with prostate-specific membrane antigen (PSMA PET-CT) demonstrated low-grade heterogeneous PSMA uptake (SUVmax 3.9) in the prostate. A transrectal ultrasound (TRUS)-guided prostate biopsy showed benign prostatic hyperplasia (BPH) with prostatitis. Following a failed voiding trial and recatheterization, the patient underwent transurethral resection of the prostate (TURP), which was uneventful. Histopathology revealed XGP with BPH. The patient had a successful postoperative recovery with effective voiding. XGP is an uncommon condition that can present with markedly elevated PSA and imaging findings suggestive of advanced PCa. This case underscores the importance of correlating histopathological findings with clinical and imaging data to avoid overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.